Health Care/Hospital

Ivory Dentin Graft(TM), the First and Only Dentin Graft, Receives CE Mark

Ivory Dentin Graft creates a new dentin category of graft substitutes for repair and augmentation of bone defects. KEFAR SAVA, Israel, Sept. 21, 2022 /PRNewswire/ -- Developed by Ivory Graft Ltd ., the Ivory Dentin Graft™ is a new dentin graft. This graft material has be...

2022-09-21 18:20 1386

MGC Pharmaceuticals Successfully Developed Herbal-inspired Products for Treatment of Long COVID and COVID-19

LONDON, Sept. 21, 2022 /PRNewswire/ -- MGC Pharmaceuticals Ltd. (LSE: MXC), (ASX: MXC), (OTC: MGCLF), is a European based bio-pharma company, focused on developing and supplying affordable (Accessible) and Ethically Produced Plant Inspired Medicines, is helping to solve the mystery of treating Lo...

2022-09-21 17:13 2922

HIKE Capital rides green wave to seize future

BEIJING and SINGAPORE, Sept. 21, 2022 /PRNewswire/ -- As the world is undergoing an energy restructuring, HIKE Capital, a leading founders' fund in China, has been committed to seizing the opportunities that emerged in the new era, which has been shaped by carbon reduction and digital technology. ...

2022-09-21 13:53 1714

Love Your Heart event to offer tips on overall and heart health

SINGAPORE, Sept. 21, 2022 /PRNewswire/ -- Farrer Park Hospital (FPH) will hold a health awareness event on Saturday, 24 September at Pek Kio Community Centre. Marking World Heart Day which falls on 29 September, the Love You...

2022-09-21 13:00 1679

Excelra partners with Patcore, Inc.

The partnership expands Excelra's scientific products footprint in the Japanese market HYDERABAD, India and TOKYO, Sept. 21, 2022 /PRNewswire/ -- Excelra today announced a partnership with Patcore, Inc., providing greater access to Excelra's scientific data and analytics products for customers i...

2022-09-21 12:30 2843

SCG Cell Therapy To Establish Cell Therapy Pilot cGMP Manufacturing Facility And R&D Centre In Singapore

SINGAPORE, Sept. 21, 2022 /PRNewswire/ -- Singapore-based SCG Cell Therapy Pte Ltd (SCG), has announced today the establishment of a state-of-the-art cell therapy research and manufacturing hub inSingapore. With the support of the Singapore Economic Development Board (EDB), the hub comprises a pi...

2022-09-21 11:00 2713

Final IPAX-1 Study Data Confirms Safety and Tolerability Profile for TLX101, Preliminary Efficacy Data

MELBOURNE, Australia, Sept. 21, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reports the final results from the IPAX-1 Ph I/II study of TLX101 therapy (4-L-[131I] iodo-phenylalanine, or 131 I-IPA) in combination with external beam radiation therapy (EBRT)...

2022-09-21 07:51 1209

Glyscend Therapeutics Releases New Phase 1 Biomarker Results and Initiates Phase 2 Clinical Trial under an IND for GLY-200 as a Potential First-in-Class Type 2 Diabetes Treatment

GLY-200 is a First-in-Class, Oral, Gut-Targeted Approach for Treatment of Type 2 Diabetes and Related Metabolic Conditions Newly Released Phase 1 Biomarker Data is Consistent with Effects of Roux-en-Y Gastric Bypass Surgery and Duodenal Exclusion Devices Initial Data from Phase 2 Trial Evaluatin...

2022-09-21 05:33 1238

Sirnaomics to Present Latest Developments on siRNA Therapeutics for Cancer and GalAhead(TM) Platform Programs at the 2nd Annual Oligonucleotide Therapeutics and Delivery Conference

GAITHERSBURG, Md. and SUZHOU, China, Sept. 20, 2022 /PRNewswire/ -- Sirnaomics Ltd . (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that it will present the la...

2022-09-20 22:40 2689

Pulnovo Medical Released Results From PADN-CFDA Pivotal Trial For The Treatment Of Pulmonary Arterial Hypertension (PAH)

SHANGHAI, Sept. 20, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platform, today released the positive results from the Pulmonary Artery Denervation (PADN)-CFDA pivotal study on Transcatheter Cardiovascular Therapy conference (TCT 2022),one of the world's most influenti...

2022-09-20 20:30 1896

Dimagi receives $25 million to develop transformative technology for Frontline Workers

Program-Related Investment from the Steele Foundation for Hope will fund next generation digital platform to support and enable critical frontline healthcare workforces globally CAMBRIDGE, Mass., Sept. 20, 2022 /PRNewswire/ -- Dimagi, a global social impact organization and leader in frontline t...

2022-09-20 20:19 1295

Menarini and SciClone Sign Exclusive Licensing Agreement to Develop and Commercialize Vaborem® in China to Treat Antimicrobial Resistant Infections

* Vaborem®, a patented combination of meropenem and vaborbactam, is expected to address the rising prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections inChina * The deal brings together Melinta's innovation, Menarini's cross-regional expertise in registration and market...

2022-09-20 17:00 2080

Jialian Biotech Group To Participate At Vitafoods Asia 2022 In Bangkok

TAIPEI, Sept. 20, 2022 /PRNewswire/ -- Leading Taiwanese health-care supplements manufacturer Jialian Biotech Group (Jialian) is excited to announce its participation in Vitafoods Asia 2022 –Asia's leading nutraceutical event – inBangkok from October 5th to October 7th, 2022.  Headquartered in T...

2022-09-20 14:01 1811

WuXi Biologics' Drug Substance and Drug Product Facilities Again Approved by U.S. FDA and EMA

WUXI, China, Sept. 20, 2022 /PRNewswire/ --WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that its two Drug Substance (DS) facilities and a Drug Product (DP) facility located in Wuxi city received reg...

2022-09-20 10:48 1697

Angel Yeast Launches Premium Dry Yeast to Cater to Changing Global Baking Needs at Bakery China 2022

SHANGHAI, Sept. 20, 2022 /PRNewswire/ -- Angel Yeast , (SH600298), the world's leading yeast manufacturer announces that it has developed the latest dry yeast product Premium Dry Yeast to address many of today's baking challenges at Bakery China 2022 -- a global large...

2022-09-20 10:47 2833

Rapid growth puts Australian CRO Accelagen on the map for clinical research globally

With over 110% revenue growth in the last two years, Accelagen announces move to new office space in Hawthorn East,Melbourne MELBOURNE, Australia, Sept. 20, 2022 /PRNewswire/ -- Accelagen , one of Australia's leading Contract Research Organisations, has taken new 472sq...

2022-09-20 09:37 2146

Unstoppable Rise of Korean Medical Tourism

KHIDI Launches Official Medical Korea Website for Easier Access to Korean Medical Services SEOUL, South Korea, Sept. 20, 2022 /PRNewswire/ -- Korea Health Industry Development Institute (KHIDI) has revamped the official website of Medical Korea(www.medicalkorea.or.kr

2022-09-20 08:00 3135

Smith+Nephew launches OR3O™ Dual Mobility System in Japan for use in primary and revision hip arthroplasty

Features proprietary OXINIUM™ DH material; eliminates Cobalt Chrome alloy reducing wear and corrosion risks1 LONDON, Sept. 20, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its OR3O Dual Mobility System for use in prim...

2022-09-20 07:00 2467

RemeGen Announces Preliminary Results of Phase III Confirmatory Study of Telitacicept for Treatment of Systemic Lupus Erythematosus (SLE) in China

YANTAI, China, Sept. 19, 2022 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, recently announced the preliminary results of the Phase III confirmatory study of its proprietary novel fusion protein Telitacicept for th...

2022-09-19 21:00 1528

Hummingbird Bioscience Chief Scientific Officer Jerome Boyd-Kirkup to Present at the 2nd Annual VISTA Virtual Symposium

SINGAPORE, Sept. 19, 2022 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced thatJerome Boyd-Kirkup, Ph.D., Hummingbird Bioscience's Chief Scientific Offic...

2022-09-19 20:00 1282
1 ... 168169170171172173174 ... 554

Week's Top Stories